Cartilaginous giant cell tumor (GCT) is a rare type of tumor that can occur in various locations in the body, including bone and soft tissue. Although this tumor is rarely cancerous, it can be aggressive and cause destruction of surrounding tissue.
Cartilaginous giant cell tumor was originally called chondroblastoma, but is now often called HCC. It arises from giant multinucleated cells that can contain up to 100 nuclei. These cells produce large amounts of cytokines and other substances that can stimulate tumor growth and development.
HCH can manifest itself in a variety of ways, depending on where it develops. If the tumor develops in the bone, it can cause pain, deformity, and brittleness of the bone. If the tumor develops in soft tissue, it can cause swelling, pain and limited movement.
To diagnose HCH, various methods can be used, such as X-ray and MRI studies, biopsy and histological analysis of tissue. Treatment may include surgical removal of the tumor, radiation therapy, and chemotherapy.
Although giant cell cartilaginous tumor is a rare disease, it can be dangerous and requires careful monitoring and treatment. Seeing your doctor quickly when symptoms appear can help diagnose and treat this tumor.